The coagulation system has gained much interest again as new anticoagulatory substances
have been introduced into clinical practice. Especially patients with renal failure are likely …

Venous thromboembolism (VTE) is a serious and often fatal medical condition with an
increasing incidence. Despite the changing landscape of VTE treatment with the introduction …

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Prior to the commencement of this
study, it was already known that rivaroxaban is partially cleared via the kidneys and an …

A score that can accurately determine the risk of major bleeding during anticoagulant
therapy may help to make decisions on anticoagulant use. RIETE is an ongoing registry of …

Objective To develop practical recommendations for the use of low-molecular-weight
heparins (LMWHs) as prophylaxis and treatment of venous thromboembolism and acute …

Patients with chronic kidney disease (CKD) have an increased risk for cardiovascular
morbidity and mortality. Little attention has been paid to the problem of atrial fibrillation …

With the rising prevalence of kidney disease, clinicians are increasingly faced with concerns
about potential thrombotic and bleeding complications. Thrombotic risk, both arterial and …

Cancer patients with acute venous thromboembolism (VTE) have an increased incidence of
recurrences and bleeding complications while on anticoagulant therapy. Methods RIETE is …

Importance Patients with venous thromboembolism (VTE) and concomitant chronic kidney
disease (CKD) have been reported to have a higher risk of thrombosis and major bleeding …

Aims Limited data are available on the impact of renal function on the outcome of patients
with atrial fibrillation (AF). Methods and results AMADEUS was a multicentre, randomized …